Home > National Drug Code (NDC) > ATACAND HCT

ATACAND HCT - 0186-0324-54 - (Candesartan cilexetil Hydrochlorothiazide)

Alphabetical Index


Drug Information of ATACAND HCT

Product NDC: 0186-0324
Proprietary Name: ATACAND HCT
Non Proprietary Name: Candesartan cilexetil Hydrochlorothiazide
Active Ingredient(s): 32; 25    mg/1; mg/1 & nbsp;   Candesartan cilexetil Hydrochlorothiazide
Administration Route(s): ORAL
Dosage Form(s): TABLET
Coding System: National Drug Codes(NDC)

Labeler Information of ATACAND HCT

Product NDC: 0186-0324
Labeler Name: AstraZeneca LP
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA021093
Marketing Category: NDA
Start Marketing Date: 20080902

Package Information of ATACAND HCT

Package NDC: 0186-0324-54
Package Description: 90 TABLET in 1 BOTTLE (0186-0324-54)

NDC Information of ATACAND HCT

NDC Code 0186-0324-54
Proprietary Name ATACAND HCT
Package Description 90 TABLET in 1 BOTTLE (0186-0324-54)
Product NDC 0186-0324
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Candesartan cilexetil Hydrochlorothiazide
Dosage Form Name TABLET
Route Name ORAL
Start Marketing Date 20080902
Marketing Category Name NDA
Labeler Name AstraZeneca LP
Substance Name CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE
Strength Number 32; 25
Strength Unit mg/1; mg/1
Pharmaceutical Classes Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient]

Complete Information of ATACAND HCT


General Information